Trial · NCT01516957
Results by group15
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 15 of 15
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an American College of Rheumatology (ACR) 20% | Placebo SC | 19.2 | 95% Confidence Interval 9.6 to 32.5 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an American College of Rheumatology (ACR) 20% | AMG 827 140 | 39.6 | 95% Confidence Interval 26.5 to 54 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an American College of Rheumatology (ACR) 20% | AMG 827 280 | 44 | 95% Confidence Interval 30 to 58.7 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an ACR 50 | Placebo SC | 3.8 | 95% Confidence Interval 0.5 to 13.2 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an ACR 50 | AMG 827 140 | 15.1 | 95% Confidence Interval 6.7 to 27.6 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an ACR 50 | AMG 827 280 | 15.7 | 95% Confidence Interval 7.0 to 28.6 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an ACR 70 | Placebo SC | 0 | 95% Confidence Interval 0 to 6.7 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an ACR 70 | AMG 827 140 | 5.7 | 95% Confidence Interval 1.2 to 15.7 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by the Proportion of Subjects Achieving an ACR 70 | AMG 827 280 | 5.9 | 95% Confidence Interval 1.2 to 16.2 | percentage of participants | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by Change From Baseline in Clinical Disease Activity Index (CDAI) | Placebo SC | -3.96 | Standard Deviation 10.32 | score on a scale | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by Change From Baseline in Clinical Disease Activity Index (CDAI) | AMG 827 140 | -11.32 | Standard Deviation 12.21 | score on a scale | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by Change From Baseline in Clinical Disease Activity Index (CDAI) | AMG 827 280 | -11.25 | Standard Deviation 9.16 | score on a scale | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by Change From Baseline in Disease Activity Score With a 28 Joint Count (DAS 28) | Placebo SC | -0.42 | Standard Deviation 1.25 | score on a scale | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by Change From Baseline in Disease Activity Score With a 28 Joint Count (DAS 28) | AMG 827 140 | -1.17 | Standard Deviation 1.39 | score on a scale | |
| To Evaluate the Efficacy of AMG 827 in Psoriatic Arthritis as Measured by Change From Baseline in Disease Activity Score With a 28 Joint Count (DAS 28) | AMG 827 280 | -1.06 | Standard Deviation 0.97 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT01516957/results